Detailed analysis at a single‐cell level of cells undergoing pancreatic differentiation
Open Access
- 3 September 2019
- journal article
- editorial
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 11 (1) , 20-21
Abstract
Pluripotent stem cells derived β‐cells are expected to be a source for cell replacement therapy of Type 1 diabetes mellitus. Several protocols have recently described the generation of pancreatic β cells. The latest report from the Douglas Melton laboratory, fully utilizing single‐cell ribonucleic acid (RNA) sequencing, provides in‐depth knowledge of stem cell pancreatic differentiation.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP19bm0804011h0403)
This publication has 5 references indexed in Scilit:
- Charting cellular identity during human in vitro β-cell differentiationNature, 2019
- Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cellsNature Cell Biology, 2019
- The Polycomb-Dependent Epigenome Controls β Cell Dysfunction, Dedifferentiation, and DiabetesCell Metabolism, 2018
- Generation of Functional Human Pancreatic β Cells In VitroCell, 2014
- Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cellsNature Biotechnology, 2014